The Types segmentation classifies AMD AI Screening Systems by deployment architecture: hardware‑based, software‑only, cloud‑based, and hybrid solutions. Hardware‑based devices combine imaging sensors with onboard AI processors, offering real‑time analysis at the point of care; their capital‑intensive nature limits market penetration but yields higher margins. Software‑only products run AI algorithms on existing imaging equipment, reducing upfront costs and appealing to cost‑conscious providers, thereby capturing a sizable portion of the market. Cloud‑based platforms host AI models on remote servers, allowing continuous updates and scalable compute resources; this model supports subscription pricing and facilitates data aggregation for population‑level insights. Hybrid offerings blend on‑device preprocessing with cloud‑centric inference, balancing latency, security, and scalability concerns. Each type contributes uniquely to total market size by aligning with differing clinical workflows, budget constraints, and regulatory environments, reinforcing the comprehensive market taxonomy for AMD AI Screening Systems.